Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
cardiac, characterize, component, coupled, COVID, difficult, Distinguishing, efficacy, environment, exact, exceeded, exposure, forecasting, forward, Hedging, history, long, lymphocyte, lymphopenia, moving, multiple, ophthalmologic, outsourced, PK, pro, pulmonary, rata, ratio, receptor, remeasured, Restated, roll, targeted, thereof, tolerability, tolerated, unanticipated, unpredictable, vitro, vivo
Removed:
crossover, derived, endpoint, IV, morphine, placebo, rollforward, shipment, treated
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view